Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11191855
1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof
granted -
US 11191844
Multispecific antigen-binding molecules and uses thereof
granted -
US 11191843
Multi-arm targeting anti-cancer conjugate
granted -
US 11191842
Injectable thermoresponsive polyelectrolytes
granted -
US 11191849
Compositions and methods for delivering messenger RNA
granted -
US 11191821
Peptide vaccine formulations and use thereof for inducing an immune response
granted -
US 11191813
Lyophilized recombinant VWF formulations
granted -
US 11191783
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11191780
Extracellular matrix compositions for the treatment of cancer or immunological diseases
granted -
US 11191818
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
granted -
US 11191935
Implant delivery system with hydration promotor capability
granted -
US 11191778
Multifunctional linker technology containing an N4 group
granted -
US 11191837
Recombinant VWF formulations
granted -
US 11192936
Factor VIII chimeric proteins and uses thereof
granted -
US 11191824
Method of purifying virus-like-particles
granted -
US 11192907
Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same
granted -
US 11191758
Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors
granted -
CA 3183290
COMPRIME COMPRENANT DE L'OPICAPONE
granted -
US 11185547
Use of reboxetine to treat narcolepsy
granted -
US 11185498
Multilayer thin film drug delivery device and methods of making and using the same
granted -
US 11185601
Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
granted -
US 11186873
Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)
granted -
US 11186625
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11186576
Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.